U

    UFP Technologies Inc (UFPT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $297.95
    -2.10 (-0.70%)

    Market Cap: $2.32B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +16.61%
    Streak
    16 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$2.69
    Range$2.57 - $2.78
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$2.73+1.7%
    60d ago$2.74+2.0%
    30d ago$2.74+2.0%
    7d ago$2.74+2.0%
    Current$2.69
    Revenue Consensus
    $167M
    Range$165M - $168M
    4 analysts
    Dec 31, 2026
    EPS Consensus$3.07
    Range$2.90 - $3.18
    4 analysts
    Revenue Consensus
    $177M
    Range$172M - $182M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.07---
    Sep 26EST
    		-$2.69---
    Jun 26
    		$2.92$2.51+16.33%Beat+16.8%
    Mar 26
    		$2.48$2.31+7.36%Beat+0.4%
    Dec 25
    		$2.44$2.20+10.91%Beat-0.8%
    Sep 25
    		$2.39$2.17+10.14%Beat+0.0%
    Jun 25
    		$2.50$2.25+11.11%Beat+34.4%
    Mar 25
    		$2.47$2.01+22.89%Beat+48.8%
    Dec 24
    		$2.46$2.13+15.22%Beat+62.9%
    Sep 24
    		$2.39$1.86+28.49%Beat+57.2%
    Jun 24
    		$1.86$1.54+20.78%Beat+18.5%
    Mar 24
    		$1.66$1.17+41.88%Beat+5.7%
    Dec 23
    		$1.51$1.14+32.46%Beat+37.3%
    Sep 23
    		$1.52$1.49+2.01%Beat+55.1%
    Jun 23
    		$1.57$1.42+10.56%Beat+175.4%
    Mar 23
    		$1.57$1.12+40.18%Beat+118.1%
    Dec 22
    		$1.10$0.91+20.88%Beat+161.9%
    Sep 22
    		$0.98$0.91+7.69%Beat+92.2%
    Jun 22
    		$0.57$0.79-27.85%Miss-8.1%
    Mar 22
    		$0.72$0.45+60.00%Beat+30.9%
    Dec 21
    		$0.42$0.41+2.44%Beat-23.6%
    Sep 21
    		$0.51$0.59-13.56%Miss+27.5%
    Jun 21
    		$0.62$0.52+19.23%Beat+82.4%
    Mar 21
    		$0.55$0.36+52.78%Beat+5.8%
    Dec 20
    		$0.55$0.42+30.95%Beat-28.6%
    Sep 20
    		$0.40$0.32+25.00%Beat-46.7%
    Jun 20
    		$0.34$0.20+70.00%Beat-45.2%
    Mar 20
    		$0.52$0.54-3.70%Miss+4.0%
    Dec 19
    		$0.77$0.60+28.33%Beat+30.5%
    Sep 19
    		$0.75$0.56+33.93%Beat+33.9%
    Jun 19
    		$0.62$0.56+10.71%Beat+14.8%
    Mar 19
    		$0.50$0.40+25.00%Beat+108.3%
    Dec 18
    		$0.59$0.58+1.72%Beat+59.5%
    Sep 18
    		$0.56$0.55+1.82%Beat+143.5%
    Jun 18
    		$0.54$0.50+8.00%Beat+45.9%
    Mar 18
    		$0.24$0.16+50.00%Beat-20.0%
    Dec 17
    		$0.37$0.23+60.87%Beat+85.0%
    Sep 17
    		$0.23$0.36-36.11%Miss+4.5%
    Jun 17
    		$0.37$0.36+2.78%Beat-
    Mar 17
    		$0.30$0.23+30.43%Beat-
    Dec 16
    		$0.20$0.23-13.04%Miss-
    Sep 16
    		$0.22N/A-54.17%Miss-

    Key Metrics

    Valuation
    P/E Ratio29.13EV/EBITDA21.13x
    Price/FCF37.55xFCF Yield2.66%
    Profitability
    Profit Margin11.50%Operating Margin16.20%
    ROE17.10%ROIC13.56%
    Financial Health
    Debt/Equity0.25xInterest Coverage12.41x
    Current Ratio3.00xQuick Ratio1.72x
    Trading Statistics
    Beta1.06Avg Volume170.43K
    52-Week High$338.7152-Week Low$173.86

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$305.23
    SMA 20$313.37
    SMA 50$275.74
    SMA 200$236.17
    EMA 10$303.98
    EMA 20$300.65
    EMA 50$279.97
    EMA 200$243.20

    MACD

    Line: 7.62Signal: 11.97Hist: -4.36

    ADX

    ADX: 28.6+DI: 21.1-DI: 19.6

    Aroon & PSAR

    Aroon Up24.0
    Aroon DownN/A
    PSAR$332.15

    Bollinger Bands

    Upper Band$333.52
    Lower Band$293.23
    %B Position1286%(Upper)
    Band Width0.12

    RSI (14-Day)

    Neutral
    51.7

    Momentum Oscillators

    Stoch %K6.1
    Stoch %D8.2
    Williams %R-90.1
    ROC (10d)-7.3%
    Momentum-23.36
    CCI (20d)-138.9
    MFI (14d)34.3

    Volatility Measures

    ATR (14d)$10.47(3.5%)
    StdDev (20d)10.07
    Hist Vol95.2%(High)

    Volume Flow

    VWAP$297.23
    OBV1.4M
    AD Line1.9M
    CMF (20d)-0.082

    Volume Metrics

    Avg Vol (20d)169.5K
    Vol Ratio0.9x
    VWMA (20d)$317.26

    Pivot Points

    R3$309.69
    R2$307.58
    R1$303.82
    Pivot Point$301.71
    S1$297.95
    S2$295.84
    S3$292.08

    Advanced Oscillators

    TSI17.62
    Ultimate Osc40.1
    KST167.46

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$173.96M$154.20M$148.91M$154.56M$151.18M$148.15M$144.07M$145.16M$110.18M$105.01M$101.50M$100.78M
    Cost of Revenue$123.05M$109.84M$106.95M$111.81M$107.63M$106.00M$102.01M$103.64M$77.15M$74.93M$75.37M$73.03M
    Gross Profit$50.92M$44.36M$41.97M$42.75M$43.54M$42.15M$42.06M$41.52M$33.03M$30.08M$26.13M$27.75M
    Operating Expenses$22.82M$21.00M$20.46M$19.37M$19.23M$19.02M$19.80M$16.76M$15.08M$14.16M$13.39M$12.71M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$22.75M$21.02M$20.97M$19.07M$18.68M$18.73M$18.62M$15.79M$13.90M$13.91M$13.12M$12.47M
    Operating Income$28.10M$23.37M$21.50M$23.38M$24.33M$23.13M$22.26M$24.76M$17.95M$15.92M$12.74M$15.04M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.71M$1.74M$1.93M$2.39M$2.67M$2.81M$3.38M$3.48M$577,000$631,000$754,000$933,000
    Income Before Tax$26.43M$21.61M$19.54M$21.06M$21.63M$20.28M$19.10M$21.22M$17.37M$15.34M$11.89M$14.14M
    Income Tax Expense$5.58M$4.11M$1.98M$4.68M$4.45M$3.10M$2.72M$4.86M$3.82M$2.64M$285,000$2.45M
    Net Income$20.85M$17.50M$17.57M$16.38M$17.18M$17.18M$16.38M$16.36M$13.55M$12.69M$11.61M$11.69M
    EBITDA$33.10M$28.24M$33.67M$21.05M$29.03M$27.72M$31.34M$24.52M$20.98M$18.96M$15.61M$17.91M
    EBIT$28.14M$23.34M$21.47M$23.46M$24.31M$23.09M$22.48M$24.69M$17.95M$15.97M$12.65M$15.07M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about UFPT

    Government Contracts

    Gov Obligations (TTM)
    -$1219
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    2
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    UFP Technologies (NASDAQ: UFPT) director to sell 7,000 shares via trust

    UFP Technologies Inc. (UFPT) director Marc D. Kozin plans to sell 7,000 shares of common stock, valued at approximately $2.14 million, through the Marc D. Kozin Revocable Trust. The shares originate from stock awards granted between 2019 and 2023. This transaction was disclosed in a Rule 144 filing, which indicates a neutral impact and sentiment according to Rhea-AI.

    Stock Titan•8/25/26•
    Neutral

    UFP Technologies Submits Updated Investor Presentation in Compliance with Regulation FD

    UFP Technologies, Inc. filed an updated investor presentation with the U.S. SEC on August 24, 2026, in compliance with Regulation FD. These materials are intended for investor meetings and public presentations, and while they contain forward-looking statements, they are not considered "filed" for liability purposes under Section 18 of the Securities Exchange Act. The filing, signed by Ronald J. Lataille, Senior Vice President, Treasurer, and CFO, advises readers to consult cautionary notes within the presentation itself regarding potential differences in actual outcomes.

    Kalkine Media•8/24/26•
    Neutral

    UFP Technologies (UFPT) outlines new 3–5 year growth and margin goals

    UFP Technologies (UFPT) has released an updated investor presentation outlining its financial performance and future targets. The company reported significant revenue growth of 3.4x from $179 million in 2020 to $603 million in 2025, alongside improved adjusted operating margins. UFPT also set new 3-5 year financial goals including 12-18% annual revenue growth, 28-31% gross margins, and 17-20% adjusted operating margins, driven by organic growth and M&A focused on high-growth medical segments.

    Stock Titan•8/24/26•
    Bullish

    UFP Technologies updates investor presentation, cites $603M 2025 revenue and 12–18% growth target

    UFP Technologies (UFPT) has updated its investor presentation, projecting $603 million in revenue for 2025, a significant increase from 2020. The company aims for 12–18% annual revenue growth, 28–31% gross margins, and 17–20% adjusted operating margins over the next 3-5 years. A key focus is on medtech, including robotic surgery, infection control, and wound care, highlighting large outsourcing opportunities.

    TradingView•8/24/26•
    Bullish

    36,030 Shares in UFP Technologies, Inc. $UFPT Purchased by Ranger Investment Management L.P.

    Ranger Investment Management L.P. has acquired 36,030 shares of UFP Technologies, Inc. (NASDAQ:UFPT) worth approximately $9.6 million, representing a 0.47% stake in the company. Institutional investors now collectively own 87.28% of UFP Technologies. The company recently surpassed earnings estimates with $2.92 EPS and exceeded revenue forecasts, although insiders have sold a significant number of shares recently.

    MarketBeat•8/24/26•
    Bullish

    Frequently Asked Questions About UFPT

    Does UFPT pay dividends?
    UFP Technologies Inc (UFPT) does not currently pay a regular dividend.
    What is UFPT's P/E ratio?
    UFP Technologies Inc has a price-to-earnings (P/E) ratio of 29.13.
    What is UFPT's market cap?
    UFP Technologies Inc (UFPT) has a market capitalization of $2.32B with a current stock price of $297.95.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In